1. Home
  2. MOH vs RDY Comparison

MOH vs RDY Comparison

Compare MOH & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molina Healthcare Inc

MOH

Molina Healthcare Inc

HOLD

Current Price

$223.27

Market Cap

9.9B

Sector

Health Care

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$12.63

Market Cap

11.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOH
RDY
Founded
1980
1984
Country
United States
India
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
11.8B
IPO Year
2002
2001

Fundamental Metrics

Financial Performance
Metric
MOH
RDY
Price
$223.27
$12.63
Analyst Decision
Hold
Strong Buy
Analyst Count
13
1
Target Price
$167.00
$16.90
AVG Volume (30 Days)
884.9K
3.0M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$45,426,000,000.00
N/A
Revenue This Year
$2.40
$7.72
Revenue Next Year
$5.18
$3.50
P/E Ratio
$837.20
$18.67
Revenue Growth
11.75
N/A
52 Week Low
$121.06
$12.19
52 Week High
$244.89
$15.67

Technical Indicators

Market Signals
Indicator
MOH
RDY
Relative Strength Index (RSI) 54.49 34.89
Support Level $175.18 $12.19
Resistance Level N/A $13.96
Average True Range (ATR) 9.45 0.37
MACD -1.64 -0.22
Stochastic Oscillator 16.88 2.35

Price Performance

Historical Comparison
MOH
RDY

About MOH Molina Healthcare Inc

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: